PCV 13, a 13-valent pneumococcal conjugate vaccine, showed a favorable safety profile and immunogenicity when administered concomitantly with DTaP, a report at at IDWeek 2012 demonstrated.
Results from a Phase 2 study reported on at IDWeek 2012 showed that the 5555 formulation of tetravalent dengue vaccine elicits the highest serpositivity rates and balanced response against all four serotypes with a satisfactory safety profile.
Alzheimer's disease (AD) symptoms stabilize among patients treated with intravenous immunoglobulin (IVIG) for 36 months.
The goal of this program is to improve management of immunizations and to review safety concerns. This program is from the 2011 Scientific Assembly of the American Academy of Family Physicians.2.00 AMA PRA Category 1 Credit(s)TM
This activity will allow these healthcare professionals to make the most up-to-date—and most appropriate—therapeutic decisions for their patients.1.00 AMA PRA Category 1 Credit(s)TM
From the December 2012 issue of The Clinical Advisor: A collaborative approach to myasthenia gravis. This chronic autoimmune disorder is caused by antibodies that block muscle cells from receiving neurotransmitters from the nerve cell.0.50 AAPA Category I CME Credit